1. Home
  2. UROY vs MOBI Comparison

UROY vs MOBI Comparison

Compare UROY & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uranium Royalty Corp.

UROY

Uranium Royalty Corp.

HOLD

Current Price

$4.14

Market Cap

404.6M

Sector

N/A

ML Signal

HOLD

Logo Mobia Medical Inc. Common Stock

MOBI

Mobia Medical Inc. Common Stock

N/A

Current Price

$13.00

Market Cap

399.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UROY
MOBI
Founded
2017
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.6M
399.7M
IPO Year
2026
2026

Fundamental Metrics

Financial Performance
Metric
UROY
MOBI
Price
$4.14
$13.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.5M
75.9K
Earning Date
03-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$279.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1,584.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.51
$10.34
52 Week High
$5.52
$15.19

Technical Indicators

Market Signals
Indicator
UROY
MOBI
Relative Strength Index (RSI) 73.94 57.67
Support Level $3.40 $12.66
Resistance Level $4.48 $15.19
Average True Range (ATR) 0.27 0.85
MACD 0.13 0.27
Stochastic Oscillator 91.37 71.79

Price Performance

Historical Comparison
UROY
MOBI

About UROY Uranium Royalty Corp.

Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.

About MOBI Mobia Medical Inc. Common Stock

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

Share on Social Networks: